EichorEICHOR
Condition: Apol1 Mediated Kidney Disease Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Apol1 Mediated Kidney Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · 79 location(s) · Maze Therapeutics · NCT06830629APOL1 Genotyping CTA Clinical Performance Study
NA · 1 location(s) · Almac Diagnostic Services LLC · NCT06839833Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · 318 location(s) · Vertex Pharmaceuticals Incorporated · NCT05312879Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
Phase 2 · 89 location(s) · AstraZeneca · NCT06824987
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.